doi: 10.1136/annrheumdis-2011-201605 34 LenertAFardoDW
SculptCare is not a compounding pharmacy and does not engage in pharmaceutical compounding as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act
Incorporate strength training to build muscle and support metabolic health
Roches US sales increased by 9%, driven largely by eye drug Vabysmo, MS drug Ocrevus, Xolair and Polivy
49 BlokhuisA
Good indicators BMI 30, or BMI 27 with comorbidities (e.g., prediabetes, hypertension) Struggled with weight despite diet/exercise Ready for supervised program + follow-ups May not qualify / caution Pregnancy or breastfeeding Personal/family history of MTC or MEN2 Active pancreatitis or severe GI disease Uncontrolled psychiatric or substance conditions without care team support What well check Medical history, medications, allergies Blood pressure, A1C/fasting glucose, basic labs Lifestyle, goals, and support plan Ready to Make the Scale Move